Dr. Desta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
292 Euclid Ave
Suite 115
San Diego, CA 92114Phone+1 619-266-3332Fax+1 619-266-6000
Education & Training
University of California Davis HealthFellowship, Gastroenterology, 1993 - 1996
St Mary's Hospital and Medical CenterResidency, Internal Medicine, 1989 - 1992
Oregon Health and Science University School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1991 - 2024- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
- 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- 142 citationsA phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.Douglas K. Rex, Raj Bhandari, Taddese Desta, Michael P. DeMicco, Cynthia Schaeffer
Gastrointestinal Endoscopy. 2018-09-01 - 59 citationsEDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.Vlad Ratziu, Mary E. Rinella, Brent A. Neuschwander-Tetri, Eric Lawitz, Douglas Denham
Journal of Hepatology. 2021-11-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
